Search results

Frequently asked questions on the Mo-99 Manufacturing Facility and the ANSTO Nuclear Medicine project.

ANSTO’s user office in Melbourne offers access to the Australian Synchrotron, a world-class research facility with over 4,000 user visits per year. ANSTO seeks collaboration and partnerships with research organisations, scientific users and commercial users.

ANSTO is responsible for the Little Forest Legacy Site (LFLS) located within the ANSTO Buffer Zone boundary. This site, formerly known as the Little Forest Burial Ground (LFBG), was used by the Australian Atomic Energy Commission (AAEC) during the 1960’s to dispose of waste containing low levels of radioactivity and beryllium oxide (non-radioactive) in a series of shallow trenches. There has been regular monitoring of the site since 1966 and the results have been reported in ANSTO’s environmental monitoring reports.

Atmospheric scientists have developed a new technique to measures the naturally-occurring radioactive gas radon for use in accurately categorising the degree of atmospheric mixing.

China’s vertical sandstone pillars studied using nuclear techniques

The Advanced Diffraction and Scattering beamlines (ADS-1 and ADS-2) are two independently operating, experimentally flexible beamlines that will use high-energy X-ray diffraction and imaging to characterise the structures of new materials and minerals.

Australian Nuclear Science and Technology Organisation (ANSTO) is committed to protecting your personal information in accordance with the Privacy Act 1988 (Cth) (Privacy Act) and the Australian Privacy Principles.

Scientists at ANSTO characterise structures with atomic detail using probes such as x-rays, electrons, neutrons and ions.

Over 250 students took part in ANSTO's annual Science and Engineering Challenge with an all-girl school taking top honours.

The Minerals consultancy group at ANSTO has expertise in chemical engineering, metallurgy, mineralogy, chemistry, geology, and radiation safety. We can support our client's project by providing process development services, technical review, and research.

An international collaboration led by The University of Sydney and supported by ANSTO has developed an advanced, innovative artificial intelligence application that could be used to help examine tissue samples and identify signs of disease/

An ANSTO radiochemist has been awarded a scholarship to carry out research at the world-renowned Sloan Kettering Cancer Center in New York.

A new nuclear medicine waste processing facility that showcases ANSTO Synroc technology is under construction.